Posted by: Kristein King -

On December 15th, 2020, Dr. Jonathan Nakashima, PhD, CSO of Certis Oncology, joined Taconic Biosciences to present a comprehensive overview of O-PDX testing.  O-PDX is a technique which uses in vivo pharmacology testing in personalized mouse models,...